0
0.5
1
1.5
2+
Mortality
75%
Improvement
Relative Risk
Ventilation
13%
Ventilation time
83%
ICU admission
49%
ICU time
71%
Hospitalization time
-9%
Ivermectin for COVID-19 Ozer et al. LATE TREATMENT
Is late treatment with ivermectin beneficial for COVID-19?
Prospective study of 120 patients in the USA
Lower mortality (p=0.095) and ventilation (p=0.2), not sig.
c19ivm.org
Ozer et al., J. Medical Virology, November 2021
Favors ivermectin
Favors control